To deeply get to know the development situation of the science and technology innovation enterprises of Jinan, the deputy director general Zhang Xu and the deputy department director et al. visited Yinfeng Biological Group for Investigation and Visiting on January 24^th, 2017. The leaders such as the deputy director general Xu Maobo of Shandong Department of Science and Technology, Lv Jiantao, the director general of Jinan Science and Technology Bureau and etc. accompany them for the investigation. Ma Xiaoqing, the vice president of Shandong Yinfeng Group and acting chairman of Yinfeng Biological Group, Pang Yong, the acting president, Shen Baijun, the chief scientist and Liu Linlin, the director of General Management Department of Yinfeng Biological Group, Liu Guojun, the general manager of Shandong Qilu Stem Cell Engineering Co., Ltd., Guo Hong, the general manager of Shandong Qilu Cell Therapy Engineering Technology Co., Ltd., Chen Shoulin, the general manager of Yinfeng Gene Technology Co., Ltd and Jia Chunsheng, the general manager of Yinfeng Hypothermal Medicine Technology Co., Ltd received them friendly and accompany them to visit around.

The deputy director general Xu Zhang et al. successively entered the Yinfeng Gene Science and Technology Laboratory, Qilu Cell Therapy Laboratory and the Yinfeng Hypothermal Medicine Research Center Laboratory to get to know the current main business and operation situation of all companies. The gene detection, cell treatment and hypothermal medicine are three main business of Yinfeng Biological Group and are the biological cutting-edge technologies with great prospects in the biological medical field at present. Development of these three business has great significance on developing the precision medicine and promoting the development of large health industry. During the period of visiting, the general managers of all companies introduced the core technology and major products of the company to the visiting leaders in detail and Zhang Xu, the deputy director general agreed with the strategic planning and the obtained scientific and technological achievements of Yinfeng Biological Group and placed great expectations on all industries of Yinfeng Biological Group. He put forward that the science and technology are the primary productive forces and shall make the science and technology really serve the people through continuous enhancement of scientific and technological innovation and improving transformation of scientific and technological achievements.

As the representation of Jinan High and New Tech Enterprises, Yinfeng Biological Group always holds the enterprise mission of “Contributing Medical Science and Technology, Guaranteeing Human Health”. The company keeps increasing science and technology input, survives on the technology, develops by the innovation and spare no efforts to the development of the biological medical industry, continuously making contribution for promoting the health career of the human. Its subordinate Gene Technology Co., Ltd. is the gene detection technology application demonstration center which is firstly approved by the National Development and Reform Commission; The Cell Treatment Co., Ltd. is the largest medical treatment and science research enterprise of human immune cells in Shandong province; Yinfeng Hypothermal Medicine Engineering Technology Research Center is dedicated to launching the researches of the hypothermal medicine field and life sciences for the tissues, organs, human body cryogenics, anabiosis and organ function maintaining, etc., which is the first hypothermal medicine center in China. Its establishment means that China has become the third nation that realizes the human body cryopreservation, after the United States and Russia, to do so.